Gaskin K - Search Results

1

Prognostic value of sweat-chloride levels in cystic fibrosis: a negative report.

Corkey CW, Corey M, Gaskin K, Levison H. Corkey CW, et al. Among authors: gaskin k. Eur J Respir Dis. 1983 Aug;64(6):434-6. Eur J Respir Dis. 1983. PMID: 6884456

2

Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas.

Kopelman H, Corey M, Gaskin K, Durie P, Weizman Z, Forstner G. Kopelman H, et al. Among authors: gaskin k. Gastroenterology. 1988 Aug;95(2):349-55. doi: 10.1016/0016-5085(88)90490-8. Gastroenterology. 1988. PMID: 3391365

3

Improved prognosis in CF patients with normal fat absorption.

Corey M, Gaskin K, Durie P, Levison H, Forstner G. Corey M, et al. Among authors: gaskin k. J Pediatr Gastroenterol Nutr. 1984;3 Suppl 1:S99-105. doi: 10.1097/00005176-198400031-00016. J Pediatr Gastroenterol Nutr. 1984. PMID: 6502398

4

Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption.

Gaskin K, Gurwitz D, Durie P, Corey M, Levison H, Forstner G. Gaskin K, et al. J Pediatr. 1982 Jun;100(6):857-62. doi: 10.1016/s0022-3476(82)80501-5. J Pediatr. 1982. PMID: 7086584

5

Pancreatic function testing in cystic fibrosis.

Durie PR, Gaskin KJ, Corey M, Kopelman H, Weizman Z, Forstner GG. Durie PR, et al. Among authors: gaskin kj. J Pediatr Gastroenterol Nutr. 1984;3 Suppl 1:S89-98. doi: 10.1097/00005176-198400031-00015. J Pediatr Gastroenterol Nutr. 1984. PMID: 6502397

6

Durie PR, Forstner GG, Gaskin KJ, Moore DJ, Cleghorn GJ, Wong SS, Corey ML. Durie PR, et al. Among authors: gaskin kj. Pediatr Res. 1986 Mar;20(3):209-13. doi: 10.1203/00006450-198603000-00002. Pediatr Res. 1986. PMID: 3703609

7

Evidence for a primary defect of pancreatic HCO3-secretion in cystic fibrosis.

Gaskin KJ, Durie PR, Corey M, Wei P, Forstner GG. Gaskin KJ, et al. Pediatr Res. 1982 Jul;16(7):554-7. doi: 10.1203/00006450-198207000-00012. Pediatr Res. 1982. PMID: 7110775 No abstract available.

8

Towards the ideal quantitative pancreatic function test: analysis of test variables that influence validity.

Schibli S, Corey M, Gaskin KJ, Ellis L, Durie PR. Schibli S, et al. Clin Gastroenterol Hepatol. 2006 Jan;4(1):90-7. doi: 10.1016/s1542-3565(05)00852-9. Clin Gastroenterol Hepatol. 2006. PMID: 16431310

9

Genetic modifiers of liver disease in cystic fibrosis.

Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, Castaldo G, Castellani C, Cipolli M, Colombo C, Colombo JL, Debray D, Fernandez A, Lacaille F, Macek M Jr, Rowland M, Salvatore F, Taylor CJ, Wainwright C, Wilschanski M, Zemková D, Hannah WB, Phillips MJ, Corey M, Zielenski J, Dorfman R, Wang Y, Zou F, Silverman LM, Drumm ML, Wright FA, Lange EM, Durie PR, Knowles MR; Gene Modifier Study Group. Bartlett JR, et al. JAMA. 2009 Sep 9;302(10):1076-83. doi: 10.1001/jama.2009.1295. JAMA. 2009. PMID: 19738092 Free PMC article.

10

Liver disease in cystic fibrosis.

Leeuwen L, Fitzgerald DA, Gaskin KJ. Leeuwen L, et al. Paediatr Respir Rev. 2014 Mar;15(1):69-74. doi: 10.1016/j.prrv.2013.05.001. Epub 2013 Jun 14. Paediatr Respir Rev. 2014. PMID: 23769887 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters